Linking electronic health data in pharmacoepidemiology: Appropriateness and feasibility
- 17 January 2020
- journal article
- research article
- Published by Wiley in Pharmacoepidemiology and Drug Safety
- Vol. 29 (1) , 18-29
Abstract
Purpose: To provide guidance on data linkage appropriateness and feasibility to plan purposeful and sustainable new linkages that advance pharmacoepidemiology and healthcare research. Planning a new data linkage requires careful evaluation to weigh the resources required with the potential overall benefits.Methods: In response to an International Society for Pharmacoepidemiology (ISPE) call for manuscripts, a working group comprised of members from academic, industry, and government determined priority content areas; appropriateness and feasibility of data linkage was selected. Within this topic, scientific and operational considerations were determined, reviewed, and formulated into key areas, and translated into 12 consensus recommendations.Results: Guidance for feasibility assessment was categorized into five key areas: (1) research objectives and justification; (2) data quality and completeness; (3) the linkage process; (4) data ownership and governance; and (5) overall value added by linkage. Within these key areas, recommendations to consider prior to initiation were developed to evaluate suitability of the linkage to meet research objectives, assess source data completeness and population coverage, and ensure well‐defined data governance standards and protections. When creating novel linked datasets, researchers must assess the feasibility of both scientific (data quality and linkage methods) and operational (access, data use and transfer, governance, and cost) aspects.Conclusions: The data linkage feasibility assessment considerations outlined can be used as a guide when designing sustainable linked data resources to generate actionable evidence in healthcare research. These recommendations were constructed for wide applicability and can be adapted depending on the geographic, structural, and data components of the linkage.Keywords
Funding Information
- International Society for Pharmacoepidemiology (n/a)
This publication has 56 references indexed in Scilit:
- Supplementing claims data with outpatient laboratory test results to improve confounding adjustment in effectiveness studies of lipid-lowering treatmentsBMC Medical Research Methodology, 2012
- Validity of cancer diagnosis in a primary care database compared with linked cancer registrations in England. Population-based cohort studyCancer Epidemiology, 2012
- Evaluation of record linkage between a large healthcare provider and the Utah Population DatabaseJournal of the American Medical Informatics Association, 2012
- Differential Record Linkage by Hispanic Ethnicity and Age in Linked Mortality StudiesJournal of Aging and Health, 2011
- Record linkage for pharmacoepidemiological studies in cancer patientsPharmacoepidemiology and Drug Safety, 2011
- The predictive value of ICD-10 diagnostic coding used to assess Charlson comorbidity index conditions in the population-based Danish National Registry of PatientsBMC Medical Research Methodology, 2011
- Linking the Iowa Women's Health Study Cohort to Medicare Data: Linkage Results and Application to Hip FractureAmerican Journal of Epidemiology, 2010
- The SAIL Databank: building a national architecture for e-health research and evaluationBMC Health Services Research, 2009
- External Validity of the Cardiovascular Health StudyMedical Care, 2009
- The cardiovascular health study: Design and rationaleAnnals of Epidemiology, 1991